Truist Financial’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
AAMU
PIP
Truist Financial's VCYT Position: Q2 2026 in Review
Truist Financial reduced its Veracyte (VCYT) stake by 9.5% in Q2 2026, selling an estimated $42.6K and leaving 9,637 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #2131.
Truist Financial first reported a position in VCYT in Q1 2020 and has held it in 21 quarters since. The position peaked at $890K in Q1 2021. 134 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Truist Financial held 9,637 shares of Veracyte worth $566K as of Q2 2026.
- Truist Financial sold 1,015 Veracyte shares in Q2 2026, an estimated $42.6K.
- Veracyte made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2131 holding.
- Truist Financial first reported a position in Veracyte in Q1 2020 and has held it in 21 quarters since.
- Truist Financial's Veracyte position peaked at $890K in Q1 2021.
- 134 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.